Among these cytokines, IL-18 is the most promising biomarker of AOSD as its serum level is particularly high in AOSD compared to other inflammatory diseases such as rheumatoid arthritis (RA), ankylosing spondylitis (AS), polymyalgia rheumatica, and sepsis [1,2,7,8]. This evidence concerns the gene IL18 and rheumatoid arthritis.